BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18029682)

  • 1. Influence of nucleoside analogue treatment on telomere length and TRF2 amount in human HL60 cells.
    Liu X; Liu J; Ogawara T; Kurashina Y; Yashi R; Saneyoshi M; Yamaguchi T
    Nucleic Acids Symp Ser (Oxf); 2007; (51):253-4. PubMed ID: 18029682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of 3'-azido-2',3'-dideoxyguanosine treatment on amounts of TERT and POT1 in human HL60 cells.
    Liu X; Ogawara T; Kurashina Y; Saneyoshi M; Yamaguchi T
    Nucleic Acids Symp Ser (Oxf); 2008; (52):491-2. PubMed ID: 18776468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mathematical model of cellular apoptosis and senescence through the dynamics of telomere loss.
    Arkus N
    J Theor Biol; 2005 Jul; 235(1):13-32. PubMed ID: 15833310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of TRF2 by radiation-induced apoptosis in HL60 cells.
    Nakagami Y; Ito M; Hara T; Inoue T
    Radiat Med; 2002; 20(3):121-9. PubMed ID: 12126084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The telomeric protein TRF2 is critical for the protection of A549 cells from both telomere erosion and DNA double-strand breaks driven by salvicine.
    Zhang YW; Zhang ZX; Miao ZH; Ding J
    Mol Pharmacol; 2008 Mar; 73(3):824-32. PubMed ID: 18025071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere shortening in human HL60 cells by treatment with 3'-azido-2',3'-dideoxynucleosides and telomerase inhibition by their 5'-triphosphates.
    Liu X; Inomata M; Ogawara T; Saneyoshi M; Yamaguchi T
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1067-71. PubMed ID: 18058538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of TRF2 with model telomeric ends.
    Khan SJ; Yanez G; Seldeen K; Wang H; Lindsay SM; Fletcher TM
    Biochem Biophys Res Commun; 2007 Nov; 363(1):44-50. PubMed ID: 17850765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XPF with mutations in its conserved nuclease domain is defective in DNA repair but functions in TRF2-mediated telomere shortening.
    Wu Y; Zacal NJ; Rainbow AJ; Zhu XD
    DNA Repair (Amst); 2007 Feb; 6(2):157-66. PubMed ID: 17055345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells.
    Gomez D; O'Donohue MF; Wenner T; Douarre C; Macadré J; Koebel P; Giraud-Panis MJ; Kaplan H; Kolkes A; Shin-ya K; Riou JF
    Cancer Res; 2006 Jul; 66(14):6908-12. PubMed ID: 16849533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of 3'-azido-2',3'-dideoxyguanosine treatment on telomere length in human telomerase-immortalized human fibroblast cells.
    Kurashina Y; Liu X; Kato C; Inoue N; Saneyoshi M; Yamaguchi T
    Nucleic Acids Symp Ser (Oxf); 2009; (53):249-50. PubMed ID: 19749354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A RAP1/TRF2 complex inhibits nonhomologous end-joining at human telomeric DNA ends.
    Bae NS; Baumann P
    Mol Cell; 2007 May; 26(3):323-34. PubMed ID: 17499040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human XPF controls TRF2 and telomere length maintenance through distinctive mechanisms.
    Wu Y; Mitchell TR; Zhu XD
    Mech Ageing Dev; 2008 Oct; 129(10):602-10. PubMed ID: 18812185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase inhibition by 3'-azido-2', 3'-dideoxynucleoside 5'-triphosphates and telomere shortening in human cultured cells by the corresponding nucleosides.
    Yamaguchi T; Liu X; Ogawara T; Inomata M; Saneyoshi M
    Nucleic Acids Symp Ser (Oxf); 2006; (50):271-2. PubMed ID: 17150922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of long-term treatment with cytosine arabinoside on telomere length in human HL60 cells.
    Yamaguchi T; Kazama K; Takashima J; Ogawara T; Iyono S; Inomata M; Saneyoshi M
    Nucleic Acids Symp Ser (Oxf); 2005; (49):289-90. PubMed ID: 17150747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3' telomeric overhang in cancer cells.
    Tahara H; Shin-Ya K; Seimiya H; Yamada H; Tsuruo T; Ide T
    Oncogene; 2006 Mar; 25(13):1955-66. PubMed ID: 16302000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Senescence induced by altered telomere state, not telomere loss.
    Karlseder J; Smogorzewska A; de Lange T
    Science; 2002 Mar; 295(5564):2446-9. PubMed ID: 11923537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomeric 3'-overhang length is associated with the size of telomeres.
    Rahman R; Forsyth NR; Cui W
    Exp Gerontol; 2008 Apr; 43(4):258-65. PubMed ID: 18280685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRF2 overexpression diminishes repair of telomeric single-strand breaks and accelerates telomere shortening in human fibroblasts.
    Richter T; Saretzki G; Nelson G; Melcher M; Olijslagers S; von Zglinicki T
    Mech Ageing Dev; 2007 Apr; 128(4):340-5. PubMed ID: 17395247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer.
    Muñoz P; Blanco R; Flores JM; Blasco MA
    Nat Genet; 2005 Oct; 37(10):1063-71. PubMed ID: 16142233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the telomeric DNA-binding protein TRF2 in the stability of human chromosome ends.
    Ancelin K; Brun C; Gilson E
    Bioessays; 1998 Nov; 20(11):879-83. PubMed ID: 9872053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.